3Marra M A;Jones S J;Astell C R.The genome sequence of the SARS-associated coronavirus[J],2003(5624).
4Van Belkum A;Struelens M;Visser A.Role of genomic typing in taxonomy,evolutionary genetics,and microbial epidemiology[J],2001(3).
5Wang G;van Dam AP;Schwartz I.Molecular typing of borrelia burgdorferi sensu lato:taxonomic,epidemiological,and clinical implications,1999.
6Speel EJ;Hopman AH;Komminoth P.Amplification methods to increase the sensitivity of in situ hybridization:play card(s),1999(47).
7Schad A;Fahimi HD;Volkl A.Expression of catalase mRNA and protein in adult rat brain:detection by nonradioactive in situ hybridization with signal amplification by catalyzed reporter deposition (ISH-CARD) and immunohistochemistry(IHC) immunofluorescence(IF)[J],2003(51).
8Celeste N;Powers.Diagnosis of Infectious Diseases:a Cytopathologist′s Perspective,1998.
9Huang TJ;Liu M;Knight LD.An electrochemical detection scheme for identification of single nucleotide polymorphisms using hairpin-forming probes[J],2002.
10Tsourkas A;Behlke MA;Bao G.Hybridization of 2′-O-methyl and 2′-deoxy molecular beacons to RNA and DNA targets[J],2002(23).
7Gianfranco Pezzino. A Guide to the Implementation of the National Electronic Disease Surveillance System (NEDSS) in Slate Public Health Ageneies[EB/OL]. Accessed at http: //www.cdc.gov/.
8Bradley. CA, Rolka. H, Walker.D, et al. BioSense: Implementation of a National Early Event Detection and Situational Awareness System[J]. MMWR Morb Mortal Wkly Rep, August 26, 2005, 54 (Suppl) : 11-19.
9Skeet MR. Laboratories and Disease Surveillance [J]. Mil Med, 2000 : 16-19.
10Global Programme for Vaccines and Immunization, Expanded Programme on Immunization, WHO, Manual for the laboratory diagnosis of measles virus infection[S] WHO, 24, 1999.
